Data‐driven homology modelling of P‐glycoprotein in the ATP‐bound state indicates flexibility of the transmembrane domains

Human P‐glycoprotein is an ATP‐binding cassette transporter that plays an important role in the defence against potentially harmful molecules from the environment. It is involved in conferring resistance against cancer therapeutics and plays an important role for the pharmacokinetics of drugs. The lack of a high resolution structure of P‐glycoprotein has hindered its functional understanding and represents an obstacle for structure based drug development. The homologous bacterial exporter Sav1866 has been shown to share a common architecture and overlapping substrate specificity with P‐glycoprotein. The structure of Sav1866 suggests that helices in the transmembrane domains diverge at the extracytoplasmic face, whereas cross‐link information and a combination of small angle X‐ray scattering and cryo‐electron crystallography data indicate that helices 6 and 12 of P‐glycoprotein are closer in P‐glycoprotein than in the crystal structure of Sav1866. Using homology modelling, we present evidence that the protein possesses intrinsic structural flexibility to allow cross‐links to occur between helices 6 and 12 of P‐glycoprotein, thereby reconciling crystallographic models with available experimental data from cross‐linking.

[1]  D. Clarke,et al.  Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. , 2006, The Biochemical journal.

[2]  A. Elofsson,et al.  Can correct protein models be identified? , 2003, Protein science : a publication of the Protein Society.

[3]  R. Cantor,et al.  The lateral pressure profile in membranes: a physical mechanism of general anesthesia. , 1997, Toxicology letters.

[4]  C. A. Shintre,et al.  Structural insights into P‐glycoprotein (ABCB1) by small angle X‐ray scattering and electron crystallography , 2008, FEBS letters.

[5]  Jeremy C. Smith,et al.  The role of dynamics in enzyme activity. , 2003, Annual review of biophysics and biomolecular structure.

[6]  Michael Wiese,et al.  Identification of Putative Binding Sites of P‐glycoprotein Based on its Homology Model , 2008, ChemMedChem.

[7]  K. Linton,et al.  Evidence for a Sav1866‐like architecture for the human multidrug transporter P‐glycoprotein , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  G. Szakács,et al.  Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. , 2006, Physiological reviews.

[9]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[10]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[11]  J. Vanderkooi The protein state of matter. , 1998, Biochimica et biophysica acta.

[12]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[13]  D. Clarke,et al.  Drug-stimulated ATPase Activity of Human P-glycoprotein Requires Movement between Transmembrane Segments 6 and 12* , 1997, The Journal of Biological Chemistry.

[14]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[15]  Geoffrey Chang,et al.  Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.

[16]  A. Ravna,et al.  Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5) , 2007, Theoretical Biology & Medical Modelling.

[17]  K. Linton,et al.  The Topography of Transmembrane Segment Six Is Altered during the Catalytic Cycle of P-glycoprotein* , 2004, Journal of Biological Chemistry.

[18]  D. Clarke,et al.  The “LSGGQ” Motif in Each Nucleotide-binding Domain of Human P-glycoprotein Is Adjacent to the Opposing Walker A Sequence* , 2002, The Journal of Biological Chemistry.

[19]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[20]  D. Clarke,et al.  Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site* , 2003, Journal of Biological Chemistry.

[21]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[22]  D. Tieleman,et al.  P‐glycoprotein models of the apo and ATP‐bound states based on homology with Sav1866 and MalK , 2007, FEBS letters.

[23]  D. Clarke,et al.  Drug Binding in Human P-glycoprotein Causes Conformational Changes in Both Nucleotide-binding Domains* , 2003, The Journal of Biological Chemistry.

[24]  D. Clarke,et al.  ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein. , 2005, Biochemistry.

[25]  K. Bostian,et al.  Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. , 2006, Biochemical pharmacology.

[26]  M. Karplus,et al.  Evaluation of comparative protein modeling by MODELLER , 1995, Proteins.

[27]  D. Clarke,et al.  Disulfide Cross-linking Analysis Shows That Transmembrane Segments 5 and 8 of Human P-glycoprotein Are Close Together on the Cytoplasmic Side of the Membrane* , 2004, Journal of Biological Chemistry.

[28]  D. Clarke,et al.  Val133 and Cys137 in Transmembrane Segment 2 Are Close to Arg935 and Gly939 in Transmembrane Segment 11 of Human P-glycoprotein* , 2004, Journal of Biological Chemistry.

[29]  Alan E. Mark,et al.  The GROMOS96 Manual and User Guide , 1996 .

[30]  M. Totrov,et al.  Waltzing transporters and 'the dance macabre' between humans and bacteria , 2007, Nature Reviews Drug Discovery.

[31]  E. Lindahl,et al.  Mesoscopic undulations and thickness fluctuations in lipid bilayers from molecular dynamics simulations. , 2000, Biophysical journal.

[32]  A. D. McLachlan,et al.  Solvation energy in protein folding and binding , 1986, Nature.

[33]  M. Sansom,et al.  Membrane protein dynamics versus environment: simulations of OmpA in a micelle and in a bilayer. , 2003, Journal of molecular biology.

[34]  Jinhui Dong,et al.  Structural Basis of Energy Transduction in the Transport Cycle of MsbA , 2005, Science.

[35]  J. Thornton,et al.  Diversity of protein–protein interactions , 2003, The EMBO journal.

[36]  D. Clarke,et al.  Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments. , 2007, Biochemistry.

[37]  K. Locher,et al.  Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.

[38]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[39]  M. Sippl Recognition of errors in three‐dimensional structures of proteins , 1993, Proteins.

[40]  D. Tieleman,et al.  Cytosolic region of TM6 in P-glycoprotein: topographical analysis and functional perturbation by site directed labeling. , 2008, Biochemistry.

[41]  H. V. van Veen,et al.  Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus. , 2008, Biochemistry.

[42]  R. Dawson,et al.  Structure and mechanism of ABC transporter proteins. , 2007, Current opinion in structural biology.